motherlodetv.net
Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today the release of its unaudited interim condensed consolidated financial statements and accompanying management’s discussion and analysis (MD&A) for the three and six months ended June 30, 2021. All financial figures contained herein are expressed in U.S. dollars (“USD”) unless otherwise noted.
Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that it has completed its previously announced offering of US$300 million in 6.875% senior unsecured notes due 2026.
Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Cardiovascular Disease Drug Market Offers Compelling Potential for First Movers, Innovators in the Space.”
Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that it has successfully priced an oversubscribed offering of US$300 million in senior unsecured notes due 2026 at a coupon rate of 6.875% (the “2026 Notes”) pursuant to Rule 144A and Regulation S of the U.S. Securities Act of 1933, as amended, (the “Act”), with closing expected to occur on or about August 9, 2021.
Renforth Resources Inc. (CNSX:RFR.CN) (OTC:RFHRF) (FSE:9RR) (“Renforth” or the “Company”) is pleased to announce that PAR-21-132 successfully twinned PAR-87-33 with several mineralized intervals, including 11.75m which gave an average assay of 3.3 g/t Au between 130.15m and 141.9m down the hole, including a sub-interval of 15.53 g/t Au over 1.75m between 136.45m and 138.2m down the hole. Assay highlights for this hole are presented below.
Grid Metals Corp. (the “Company“) (TSXV:GRDM)(OTCQB:MSMGF) is pleased to provide a shareholder update for its projects located in Ontario Canada. The drill program at Bannockburn Nickel is completed and the Company is awaiting assay results from the remaining seven drill holes submitted for assay. At the East Bull Lake Palladium Property first results from a sampling program over new prospective drill target areas are now pending with select samples expected in early August. At East Bull seven target areas are being field investigated in the summer field program which will assist in targeting for the upcoming phase of drilling.
Lucky Minerals Inc.(TSXV:LKY)(OTC PINK:LKMNF)(FSE:LKY) (‘Lucky‘ or the ‘Company‘) is pleased to announce it has received sample assay results from its ongoing work at the Wayka epithermal gold discovery at its 100% owned Fortuna Property (‘Fortuna’) in southern Ecuador. Systematic sampling has returned an average of 17.63 g/t over 3.0 meters with one sample returning 26.50 g/t gold. (See below for further detail).
Tocvan Ventures Corp. (CSE:TOC) (CNSX:TOC.CN) (OTC:TCVNF) (“Tocvan” or the “Corporation”) is pleased to announce that the Company has been approved to list the company’s common shares on the OTCQB® Venture Marketplace (the “OTCQB Venture”) Investors are now able to trade securities on the OTCQB exchange. the trading symbol is “TCVNF”
Tocvan Ventures Corp. (CSE:TOC) (CNSX:TOC.CN) (“Tocvan” or the “Corporation”) is pleased to announce final drill results from its Phase II drill program (the “Program”) at the Pilar Gold-Silver Project in Sonora, Mexico. A Phase II drill program was completed in June with over 3,500 meters of reverse circulation (RC) drilling in twenty (20) drill holes. Final results are included in this release, highlighted by drill hole JES-21-50 which returned 39.7 meters at 0.96 g/t Au in a 50 meter step-out to the Main Zone on trend with drill hole JES-21-47 which intersected 47.3 meters at 0.75 g/t Au. In addition, the first reconnaissance drill hole at the Triple Vein Zone (TVZ) was completed 400 meters to the east (JES-21-56) and was successful in intersecting mineralization at depth, returning 1.5 meters at 0.6 g/t Au and 139 g/t Ag.
Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is extremely pleased to issue partial results from human clinical study HYPER-H21-1 evaluating DehydraTECHTM-processed cannabidiol (“CBD”) for potential application against hypertension. Partial results related to blood pressure (“BP”) are being released today, while additional BP subset analyses and all other data analyses including pharmacokinetic (“PK”) evaluations and detailed blood chemistry work is in progress and will be released when complete.